Wataru Sugiura 1/9/25 Wataru Sugiura 1/9/25

COVID-19 Relapse and Viral Evolution in a Good Syndrome Patient: A Case Study

Read More

Nicholas C. Riola 1/9/25 Nicholas C. Riola 1/9/25

In vitro antiviral activity of obeldesivir and GS-441524 in combination with oral SARS-CoV-2 therapeutics nirmatrelvir/ritonavir or molnupiravir

Read More

Mahta Mortezavi 1/9/25 Mahta Mortezavi 1/9/25

Virologic Response and Safety After Oral Administration of PF-07817883, a Novel SARS-CoV-2 Mpro inhibitor, in Nonhospitalized Adults With Symptomatic COVID-19

Read More

David C. McGowan 1/9/25 David C. McGowan 1/9/25

Discovery and Preclinical Profile of ALG-097558, a SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Read More

Andrea Cox 12/24/24 Andrea Cox 12/24/24

Systems immunology defines immunological profiles associated with long COVID onset and recovery

Read More

Vincent Marconi 12/24/24 Vincent Marconi 12/24/24

Aging from COVID-19

Read More

Dirk Jochmans 12/24/24 Dirk Jochmans 12/24/24

Inhibitors of SARS-CoV-2 Assembly

Read More